CD4 and inflammatory bowel disease: Recent immunological findings have reinforced this concept: Cook et al. (2024) [31] demonstrated that IBD patients without any documented history of C. difficile infection display evidence of prior, subclinical exposure to TcdB, with significantly increased circulating TcdB-specific CD4+ T cells compared with healthy controls.